CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P18
Within normal range
vs 5Y Ago
-1410.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -86.31% |
| Q3 2025 | -9139.61% |
| Q2 2025 | -100.65% |
| Q1 2025 | 24.63% |
| Q4 2024 | 229.08% |
| Q3 2024 | 187.79% |
| Q2 2024 | -147.38% |
| Q1 2024 | 1547.67% |
| Q4 2023 | -72.03% |
| Q3 2023 | 375.25% |
| Q2 2023 | 67.17% |
| Q1 2023 | 62.27% |
| Q4 2022 | 69.81% |
| Q3 2022 | 1.46% |
| Q2 2022 | 7.77% |
| Q1 2022 | -21.93% |
| Q4 2021 | -16.14% |
| Q3 2021 | -17.36% |
| Q2 2021 | -23.72% |
| Q1 2021 | -5.80% |
| Q4 2020 | 0.06% |
| Q3 2020 | 6.18% |
| Q2 2020 | -228.46% |
| Q1 2020 | 134.42% |
| Q4 2019 | -49.61% |
| Q3 2019 | 18.17% |
| Q2 2019 | -105.04% |
| Q1 2019 | 56.18% |
| Q4 2018 | -37.57% |
| Q3 2018 | -74.25% |
| Q2 2018 | 13.21% |
| Q1 2018 | -2594.85% |
| Q4 2017 | 106.06% |
| Q3 2017 | 59.36% |
| Q2 2017 | -205.39% |
| Q1 2017 | 41.16% |
| Q4 2016 | 4.29% |
| Q3 2016 | -3.43% |
| Q2 2016 | 11.56% |
| Q1 2016 | -39.54% |